IFNK antibody (AA 35-129)

Catalog No. ABIN566044

Product Details anti-IFNK Antibody

Target: IFNK (Interferon, kappa (IFNK))

Binding Specificity: AA 35-129

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This IFNK antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Purpose: Mouse monoclonal antibody raised against a partial recombinant IFNK.

Sequence: VHLRRVTWQN LRHLSSMSNS FPVECLRENI AFELPQEFLQ YTQPMKRDIK KAFYEMSLQA FNIFSQHTFK YWKERHLKQI QIGLDQQAEY LNQCL

Cross-Reactivity: Human

Characteristics: Antibody Reactive Against Recombinant Protein.

Immunogen: IFNK (NP_064509, 35 a.a. ~ 129 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.

Clone: 1B7

Isotype: IgG2a

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Buffer: In 1x PBS, pH 7.4

Handling Advice: Aliquot to avoid repeated freezing and thawing.

Storage: -20 °C

Storage Comment: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

References for anti-IFNK antibody (ABIN566044)

Reiser, Hurst, Voges, Krauss, Münch, Iftner, Stubenrauch: "High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression." in: Journal of virology, Vol. 85, Issue 21, pp. 11372-80, (2011) (PubMed).

Rincon-Orozco, Halec, Rosenberger, Muschik, Nindl, Bachmann, Ritter, Dondog, Ly, Bosch, Zawatzky, Rösl: "Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells." in: Cancer research, Vol. 69, Issue 22, pp. 8718-25, (2009) (PubMed).

Target Details for IFNK

Target: IFNK (Interferon, kappa (IFNK))

Alternative Name: IFNK (IFNK Products)

Synonyms: IFNK antibody, IFNT1 antibody, INFE1 antibody, RP11-27J8.1 antibody, interferon kappa antibody, IFNK antibody, Ifnk antibody

Background: Full Gene Name: interferon, kappa
Synonyms: RP11-27J8.1

Gene ID: 56832

NCBI Accession: NM_020124